Evidence map›Paper›PMID 23198734›Full record

ArticleTropical medicine & international health : TM & IH2013

Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria.

Jessica T Lin, Bernard Mbewe, Steve M Taylor, Mari Luntamo, Steven R Meshnick, Per Ashorn

Registry-linked trialAbstract read
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00131235 (Lungwena Antenatal Intervention Study. A Single-centre Intervention Trial in Rural Malawi, Testing Maternal and Infant Health Effects of Presumptive Intermittent Treatment of Pregnant Women With Sulfadoxine-pyrimethamine and Azithromycin), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00131235 phase3active not recruitingnot on this map

Lungwena Antenatal Intervention Study. A Single-centre Intervention Trial in Rural Malawi, Testing Maternal and Infant Health Effects of Presumptive Intermittent Treatment of Pregnant Women With Sulfadoxine-pyrimethamine and Azithromycin

TypeinterventionalSponsorTampere UniversityRan2003 to 2027Enrolled1,320ConditionsMalaria, Sexually Transmitted Diseases, Preterm Birth, PregnancyArmsSulfadoxine-pyrimethamine treatment twice during pregnancy, Sulfadoxine-pyrimethamine at 4-week intervals, Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twice
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Revisiting Azithromycin for Intermittent Preventive Treatment in Pregnancy.The American journal of tropical medicine and hygiene · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Jessica T LinDivision of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA. jessica_lin@med.unc.edu
Bernard Mbewe
Steve M Taylor
Mari Luntamo
Steven R Meshnick
Per Ashorn
University of North Carolina at Chapel Hill · USTampere University · FIUniversity of Malawi · MW

Funding

NIAID NIH HHS L30 AI102041
6 · The paper itself

Abstract

In the context of an Intermittent preventive treatment (IPTp) trial for pregnant women in Malawi, Plasmodium falciparum samples from 85 women at enrollment and 35 women at delivery were genotyped for mutations associated with sulfadoxine-pyrimethamine resistance. The prevalence of the highly resistant haplotype with mutations at codons 51 and 108 of dihydrofolate reductase (dhfr) and codons 437 and 540 of dihydropteroate synthase (dhps) increased from 81% at enrollment to 100% at delivery (P = 0.01). Pregnant women who were smear-positive at enrollment were more likely to have P. falciparum parasitemia at delivery. These results lend support to concerns that IPTp use may lead to increased drug resistance in pregnant women during pregnancy and emphasise the importance of screening pregnant women for malaria parasites in areas with prevalent SP resistance even when they are already on IPTp.

Indexed as

MutationAntimalarialsDihydropteroate SynthaseDNA, ProtozoanDrug CombinationsDrug ResistanceFemaleGenotypeHaplotypesHumansMalaria, FalciparumMalawiPlasmodium falciparumPolymerase Chain ReactionPregnancyPregnancy Complications, ParasiticAntimalarialsDihydropteroate SynthaseDNA, ProtozoanDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineTetrahydrofolate Dehydrogenase

Identifiers

PMID23198734
PMCPMC3553254
OpenAlexW2077835796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.